Fabry disease: open trials in China

• NCT00196742

  Fabry Disease Registry & Pregnancy Sub-registry

  Research · Genzyme, a Sanofi Company

  Beijing · Hangzhou · Jinan · Nanjing · Shanghai · Shanghai · Shanghai

  Registry updated 2026-10-14

• NCT06539624

  Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease

  Trial Treatment · The Children's Hospital of Zhejiang University School of Medicine

  Children's Hospital, Zhejiang University School of Medicine, Hangzhou · Shanghai Children's Medical Center, Shanghai

  Registry updated 2026-02-27

• NCT07336394

  Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques

  Research · Chinese Academy of Medical Sciences, Fuwai Hospital

  Fuwai Hospital, Beijing

  Registry updated 2026-01-21

• NCT07187440

  A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease

  Research · Takeda

  Peking University First Hospital, Beijing · Peking University Third Hospital, Beijing · Peking Union Medical College Hospital, Beijing · West China Hospital of Sichuan University, Chengdu · Fuzhou University Provincial Affiliated Hospital, Fuzhou · The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou · The Second Affiliated Hospital of Harbin Medical University, Harbin · The First Affiliated Hospital of USTC(Anhui Provincial Hospital), Hefei · The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing · Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing · Shantou Central Hospital, Shantou · The University of Hong Kong-Shenzhen Hospital, Shenzhen · The Second Hospital of Hebei Medical University, Shijiazhuang · The First Affiliated Hospital of Soochow University, Suzhou · Second hospital of Shanxi Medical University, Taiyuan · Tianjin Chest Hospital, Tianjin · The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an

  Registry updated 2026-01-02

• NCT06512571

  CVI Alterations in FD: a Prospective, Multicenter, Observational Cohort Study

  Research · China National Center for Cardiovascular Diseases

  Fuwai Hospital, National Centre for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

  Registry updated 2025-03-26

• NCT06819514

  The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease

  Trial Treatment · Phase 1/2 · Guangzhou Jiayin Biotech Ltd

  Children's Hospital, Zhejiang University School of Medicine, Hangzhou · First Affiliated Hospital of Zhejiang University, Hangzhou · General Hospital of Eastern Theater Command, Nanjing

  Registry updated 2025-02-11

• NCT06207552

  Evaluation of the Safety, Tolerability and Efficacy of a Gene Therapy Drug for the Treatment of Pediatric Fabry Disease

  Trial Treatment · Early phase 1 · Children's Hospital of Fudan University

  Children's Hospital Of Fudan University, Shanghai

  Registry updated 2024-07-09

All Fabry disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error